Concepts for critical organ dosimetry in three-dimensional image-based breast brachytherapy

被引:17
作者
Berger, Daniel [1 ]
Kauer-Dorner, Daniela [1 ]
Seitz, Wolfgang [1 ]
Poetter, Richard [1 ]
Kirisits, Christian [1 ]
机构
[1] Med Univ Vienna, Gen Hosp Vienna, Dept Radiotherapy, A-1090 Vienna, Austria
关键词
Brachytherapy; Breast; Organ at risk; Skin; Image-based dosimetry;
D O I
10.1016/j.brachy.2008.08.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: To investigate dose-volume histogram (DVH) parameters for organs at risk (OARs) in sectional three-dimensional image-based accelerated partial breast irradiation. METHODS AND MATERIALS: Skin, lung, and ribs were defined as OARs and the heart was discussed. Two different skin-contouring methods were tested on phantom before applying to the patient cohort. First, an inside skin wall contour was delineated with three different wall thicknesses to demonstrate the influence of contouring on DVH parameter. Second a structure was defined, delineated outside of the phantom surface, such that a three-dimensional skin volume was extended like a virtual bolus contour. Point dose values and DVH parameters were reported for 25 patient cases. RESULTS: The DVH parameters D-0.1 (cc) = 65 +/- 21, D-1 cc = 45 +/- 8, D-10 cc = 30 +/- 4 cGy/pulse for the outside skin structure around the breast corresponded to skin surface areas of 1 +/- 1, 6 +/- 3, and 6 +/- 11 cm(2). Lung volume receiving 20 Gy(alpha beta 3) was 8.3 +/- 11 cm(3). D-0.1 cc and D-2 cc in the most exposed rib were 0.7 +/- 0.3 and 0.4 +/- 0.2 Gy/pulse, respectively. CONCLUSION: In accelerated partial breast irradiation treatment planning, dose to OAR can be reported in a more sophisticated way with DVH parameters than using points only. The suggested method of skin delineation using the defined outside structure allows calculating reliable and reproducible DVH parameters. (C) 2008 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:320 / 326
页数:7
相关论文
共 33 条
[1]  
Cuttino Laurie W, 2005, Brachytherapy, V4, P10, DOI 10.1016/j.brachy.2004.11.002
[2]   Calculation of integrated biological response in brachytherapy [J].
Dale, RG ;
Coles, IP ;
Deehan, C ;
ODonoghue, JA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (03) :633-642
[4]   3D CT-based high-dose-rate breast brachytherapy implants: Treatment planning and quality assurance [J].
Das, RK ;
Patel, R ;
Shah, H ;
Odau, H ;
Kuske, RR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (04) :1224-1228
[5]   Quality assurance of treatment plans for interstitial and intracavitary high-dose-rate brachytherapy [J].
Das, Rupak K. ;
Bradley, Kristin A. ;
Nelson, Ian A. ;
Patel, Rakesh ;
Thomadsen, Bruce R. .
BRACHYTHERAPY, 2006, 5 (01) :56-60
[6]   PULSED BRACHYTHERAPY - THE CONDITIONS FOR NO SIGNIFICANT LOSS OF THERAPEUTIC RATIO COMPARED WITH TRADITIONAL LOW-DOSE RATE BRACHYTHERAPY [J].
FOWLER, J ;
MOUNT, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 23 (03) :661-669
[7]   Lung and cardiac tissue doses in left breast cancer patients treated with single-source breast brachytherapy compared to external beam tangent fields [J].
Garza, Richard ;
Albuquerque, Kevin ;
Sethi, Anil .
BRACHYTHERAPY, 2006, 5 (04) :235-238
[8]   The use of the source-skin distance measuring bridge indeed reduces skin teleangiectasia after interstitial boost in breast conserving therapy [J].
Georg, P ;
Georg, D ;
Van Limbergen, E .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) :323-330
[9]   Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) [J].
Graham, MV ;
Purdy, JA ;
Emami, B ;
Harms, W ;
Bosch, W ;
Lockett, MA ;
Perez, CA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (02) :323-329
[10]   Adjuvant stereotactic permanent seed breast implant: A boost series in view of partial breast irradiation [J].
Jansen, Nicolas ;
Deneufbourg, Jean-Marie ;
Nickers, Philippe .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (04) :1052-1058